Chiome Bioscience Inc. reported non-consolidated earnings results for the first quarter ended March 31, 2018. For the quarter, the company reported net sales of ¥45 million compared to ¥55 million, operating loss of ¥302 million compared to ¥203 million, ordinary loss of ¥300 million compared to ¥204 million and net loss of ¥301 million or ¥11.25 per share compared to ¥205 million or ¥7.93 per share for the last year. Loss before income taxes was ¥300.6 million compared to ¥204.6 million a year ago.